Determinations of the antimutagenic activities of several probiotic bifidobacteria under acidic and bile conditions against benzo[a]pyrene by a modified Ames test

International Journal of Food Microbiology

Volumn 93, Issue 2, 2004, Pages 249-257

  Lo, Pei Ren ^a   Yu, Roch Chui ^b   Chou, Cheng Chun ^b   Huang, E Chu ^b  

^a CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Ames test; Antimutagenicity; Benzo a pyrene; Bifidobacteria; Bile; pH

Indexed keywords

BENZO[A]PYRENE; BILE ACID; BILE SALT; PYRENE DERIVATIVE;

ACIDITY; ALKALINITY; AMES TEST; ARTICLE; BACTERIAL CELL; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; BILE; CELL VIABILITY; CONTROLLED STUDY; FOOD ANALYSIS; GENE MUTATION; MILK; MUTAGENIC ACTIVITY; NONHUMAN; REACTION TIME; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIMUTAGENIC AGENTS; BENZO(A)PYRENE; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; HYDROGEN-ION CONCENTRATION; MILK; PROBIOTICS; SALMONELLA TYPHIMURIUM;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; SALMONELLA TYPHIMURIUM;

EID: 2342521254     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2003.11.008     Document Type: Article

References (39)

1. Abdelali H., Cassand P., Soussotte V., Koch-Bocabeille B., Narbonne J.F. Antimutagenic activity of components of dairy products. Mutat. Res. 331:1995;133-141
2. Alexandrov K., Rojas M., Kadlubar F.F., Lang N.P., Bartsch H. Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa. Carcinogenesis. 17:1996;2081-2083
3. Arunachalam K.D. Role of bifidobacteria in nutrition, medicine and technology. Nutr. Res. 19:1999;1559-1597
4. Conway P.L., Gorbach S.L., Goldin B.R. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J. Dairy Sci. 70:1987;1-12
5. El-Nezami H., Kankaanpaa P., Salminen S., Ahokas J. Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media. J. Food Prot. 61:1998;466-468
6. Erkkila S., Petaja E. Screening of commercial meat starter cultures at low pH and in the presence of bile salts for potential probiotic use. Meat Sci. 55:2000;297-300
7. Ferguson L.R. Antimutagens as cancer chemopreventive agents in the diet. Mutat. Res. 307:1994;395-410
8. Goldin B.R., Swenson L., Dwyer J., Sexton M., Gorbach S.L. Effects of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J. Natl. Cancer Inst. 64:1980;255-261
9. Gomes A.M.P., Malcata F.X. Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends Food Sci. Technol. 10:1999;139-157
10. Hall M., Grover P.L. Polycyclic aromatic hydrocarbons: metabolism, activation, tumor initiation. Cooper C.S., Grover P.L. Chemical Carcinogenesis and Mutagenesis. vol. 1:1990;327-372 Raven Press, New York
11. Hayatsu H., Arimoto S., Negishi T. Dietary inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 202:1988;429-446
12. Hori Y., Nakamura K., Yamamoto M., Shimada K., Shibuya N., Yoshida K., Ogoshi K., Kinebuchi H., Araki K. Geographical variations in the concentration of biliary free fatty acids with anti-mutagenic action. Mutat. Res. 444:1999;41-47
13. Kazerouni K., Sinhi R., Hsu C.H., Greenberg A., Rothman N. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem. Toxicol. 39:2001;423-436
14. Lankaputhra W.E.V., Shah N.P. Survival of Lactobacillus acidophilus and Bifidobacterium spp. in the presence of acid and bile salts. Cult. Dairy Prod. J. 30:1995;2-7
15. Lankaputhra W.E.V., Shah N.P. Antimutagenic properties of probiotic bacteria and of organic acids. Mutat. Res. 397:1998;169-182
16. Lo P.R., Yu R.C., Chou C.C., Tsai Y.H. Antimutagenic activity of several probiotic bifidobacteria against benzo[a]pyrene. J. Biosci. Bioeng. 94:2002;148-153
17. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113:1983;173-215
18. Mitsuoka T. Significance of dietary modulation of intestinal flora and intestinal environment. Biosci. Microflora. 19:2000;15-25
19. Morotomi M., Mutai M. In vitro binding of potent mutagenic pyrolysates by intestinal bacteria. J. Natl. Cancer Inst. 77:1986;195-201
20. Nadathur S.R., Gould S.J., Bakalinsky A.T. Antimutagenic activity of an acetone extract of yogurt. Mutat. Res. 334:1995;213-224
21. Orrhage K., Sillerstrom E., Gustafsson J.A., Nord C.E., Rafter J. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat. Res. 311:1994;239-248
22. Penning T.M., Ohnishi S.T., Ohnishi T., Harvey R.G. Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem. Res. Toxicol. 9:1996;84-92
23. Phillips D.H. Polycyclic aromatic hydrocarbons in the diet. Mutat. Res. 443:1999;139-147
24. Pochart P., Marteau P., Bouhnik Y., Goderel I., Bourlioux P., Rambaud J.C. Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am. J. Clin. Nutr. 55:1992;78-80
25. Prasad J., Gill H., Smart J., Gopal P.K. Selection and characterization of Lactobacillus and Bifidobacterium strains for use as probiotics. Int. Dairy J. 8:1998;993-1002
26. Rasic J., Kurmann J. Bifidobacteria and their role. Experientia, Suppl. 39:1983;81-101
27. Sekine K., Toida T., Saito M., Kuboyama M., Kawashima T., Hashimoto Y. A new morphologically characterized cell wall preparation from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Res. 45:1985;1300-1307
28. Shibuya N., Nakadaira H., Ohta T., Nakamura K., Hori Y., Yamamoto M., Saitoh Y., Ogoshi K. Co-mutagenicity of glyco- and tauro-deoxycholic acids in the Ames test. Mutat. Res. 395:1997;1-7
29. Simon G.L., Gorbach S.L. Intestinal flora and gastrointestinal function. Johnson L.R. Physiology of the Gastrointestinal Tract. vol. 2, 2nd ed. 1987;1729-1747 Raven Press, New York
30. Sreekumar O., Hosono A. Antimutagenic activity and influence of physical factors in binding Lactobacillus gasseri and Bifidobacterium longum cells to amino acid pyrolysates. J. Dairy Sci. 81:1998;1508-1516
31. Sreekumar O., Hosono A. The antimutagenic properties of a polysaccharide produced by Bifidobacterium longum and its cultured milk against some heterocyclic amines. Can. J. Microbiol. 44:1998;1029-1036
32. Statistical Analytical System SAS User's Guide: Statistics. 1999;Statistical Analytical System Institute, Cary, NC
33. Sugimura T., Nagao M., Wakabayashi K. Carcinogenicity of food mutagens. Environ. Health Perspect. 104:1996;429-433
34. Tanaka H., Doesburg K., Iwasaki T., Mierau I. Screening of lactic acid bacteria for bile salt hydrolase activity. J. Dairy Sci. 82:1999;2530-2535
35. Yamada K., Lim B.O., Nonaka M., Sugano M. Measurements of mutagenic and antimutagenic activities of bile acids by Rec-assay. Biosci. Biotechnol. Biochem. 57:1993;599-602
36. Zeiger E. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity. Cancer Res. 47:1987;1287-1296
37. Zhang X.B., Ohta Y. Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens. J. Dairy Sci. 74:1991;1477-1481
38. Zhang X.B., Ohta Y. In vitro binding of mutagenic pyrolysates to lactic acid bacterial cells in human gastric juice. J. Dairy Sci. 74:1991;752-757
39. Zhang X.B., Ohta Y. Antimutagenic activity of cell fractions of microorganisms on potent mutagenic pyrolysates. Mutat. Res. 298:1993;247-253